![]() ViewPoint Therapeutics ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts. | ![]() Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. | ![]() Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. | |
Founding Date | Founding Date 2014 | Founding Date 2004 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations San Mateo, US HQ San Francisco, US | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations New York, US HQ Copenhagen, DK Nutley, US |
Employees | Employees 1 | Employees 158 | Employees 3239% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $87.7m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $15m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $72.7m (FY, 2024) |
Net income | Net income N/A | Net income (CHF61.7m) (FY, 2025) | Net income ($29.7m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 39m | Total funding raised N/A | Total funding raised $ 80m |

Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View company
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
View company